AI-supported mammography screening reduces advanced breast cancer rates and improves early detection, according to the largest randomized controlled trial to date.
Key Details
- 1Over 100,000 Swedish women were randomized to AI-supported vs. standard double-reading mammography screening.
- 2AI-supported screening resulted in a 12% reduction in interval (between-screening) breast cancer diagnoses.
- 316% fewer invasive, 21% fewer large, and 27% fewer aggressive subtype cancers were identified in the AI arm.
- 481% of cancers were detected at screening with AI, versus 74% in the control group—a 9% increase.
- 5False positive rates were similar between groups (1.5% AI, 1.4% control), and radiologist workload was reduced by 44% in interim analyses.
- 6The study supports use of tested AI tools as an aid—not a replacement—for radiologists, especially amid workforce shortages.
Why It Matters
This landmark trial shows substantial clinical benefit and workflow relief from using AI in breast cancer screening, supporting adoption in radiology programs facing growing patient volumes and staff shortages. The findings may shape future screening guidelines and training requirements for imaging AI use.
Source
EurekAlert
Related News
•EurekAlert
Distinct Patterns of Cognitive Decline Revealed by Biomarker Imaging in Alzheimer's
A study using brain imaging and biomarker data identified three distinct patterns of cognitive decline in people with preclinical Alzheimer's disease.
•EurekAlert
AI-Driven Decision Support Systems Reviewed for Heart Care Impact
A systematic review explores how AI-based clinical decision support systems can enhance cardiovascular disease management while facing adoption and equity challenges.
•EurekAlert
Stanford Study: Physicians Plus AI Chatbots Improve Clinical Decision-Making
Stanford-led studies show that physicians supported by AI chatbots match or exceed chatbot-alone performance in nuanced clinical decision-making.